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MINI-REVIEW MINI-REVIEW
Introduction
Rho family small GTPases mediate multiple aspects of tumor 
progression including cell transformation, cytokinesis, angiogen-
esis, extracellular matrix deposition and tumor cell dissemina-
tion. Rho GTPases belong to the Ras superfamily and consist 
of more than 20 members of 20–30 KDa GTP-binding proteins 
in mammals. Like Ras, Rho GTPases act as molecular switches 
by cycling from GTP bound active state to GDP bound inac-
tive state. The cycling between these two states is positively 
controlled by guanine nucleotide-exchange factors (GEFs), and 
negatively regulated by its intrinsic GTPase activity, GTPase 
activating proteins (GAPs) and guanine nucleotide-dissociation 
inhibitors (GDIs).1-3 The major function of Rho small GTPases 
is the coordination of actin cytoskeleton reorganization in 
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RhoA is one of the more extensively studied members of the 
Rho family of small GTPase where it is most readily recognized 
for its contributions to actin-myosin contractility and stress 
fiber formation. Accordingly, RhoA function during cell 
migration has been relegated to the rear of the cell where 
it mediates retraction of the trailing edge. However, RhoA 
can also mediate membrane ruffling, lamellae formation 
and membrane blebbing, thus suggesting an active role in 
membrane protrusions at the leading edge. With the advent 
of fluorescence resonance energy transfer (FRET)-based 
Rho activity reporters, RhoA has been shown to be active 
at the leading edge of migrating cells where it precedes 
Rac and Cdc42 activation. These observations demonstrate 
a remarkable versatility to RhoA signaling, but how RhoA 
function can switch between contraction and protrusion has 
remained an enigma. This review highlights recent advances 
regarding how the cooperation of Rho effector Rhotekin and 
S100A4 suppresses stress fiber generation to permit RhoA-
mediated lamellae formation.
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response to receptor activation (including growth factor, cyto-
kine and adhesion receptors), which in turn regulates GEF and 
GAP activities.3,4
Most notably, the members of the Rho family of small GTPases 
are renowned for their contributions to actin cytoskeletal reor-
ganization that drive cell motility and invasion. These concepts 
were brought to the forefront based on landmark findings by 
Ridley, Hall and colleagues in 1992 when they documented that 
Rac stimulated the formation of lamellae5 while RhoA mediated 
stress fiber formation.6 In the intervening two decades, our vision 
of Rac mediating lamellae formation and its importance to cell 
motility remains constant while many of the details of how these 
processes are regulated has been elucidated (reviewed in refs. 3 
and 4). In contrast, the literature regarding RhoA’s role in the 
migration and invasion is more conflicting, perhaps due to the 
greater versatility to RhoA functions.
The Rho subgroup of Rho GTPases, including RhoA, RhoB 
and RhoC, share about 85% amino acid sequence identity where 
the primary differences are found in the C-terminal hypervari-
able region.3 Given that Rho proteins play important roles in 
cell migration, actin cytoskeleton reorganization, and focal 
adhesion, it is well accepted that Rho signaling should contrib-
ute to tumor invasion and metastasis. Indeed, RhoA and RhoC 
have been shown to be involved in different stages of tumor pro-
gression such as loss of apical-basal polarity and cell junctions, 
intravasation and vascularization.7 There is substantial evidence 
to support the involvement of aberrant expression of Rho, espe-
cially RhoC in the metastatic capacity of different types of can-
cers, such as breast, colon, prostate, lung, head and neck and 
pancreatic.7,8 In contrast, most studies suggest that RhoB acts as 
a tumor suppressor and is generally downregulated in cancers.3,8 
RhoA and RhoC are equally capable of mediating stress fiber 
formation and generating contractile force needed for retraction 
of the trailing edge during migration. However, recent stud-
ies utilizing Rho activity biosensors suggest that RhoA is also 
activated at the leading edge of the migrating cells9,10 and, thus, 
validate several reports that demonstrate that RhoA functions 
in membrane ruffling and lamellae formation.9,11-13 Additionally, 
RhoA has been implicated in membrane blebbing, which has 
been implicated in amoeboid-like motility (reviewed in ref. 14). 
In light of these observations, our perceptions of the role of Rho 
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However, many studies demonstrating a positive role for 
RhoA in migration prompted to the concept that Rac and RhoA 
were spatially separated during cell migration such that Rac was 
activated at the leading edge and RhoA was activated at the trail-
ing edge.19 With the advent of FRET-based Rho GTPase activity 
biosensors, the hypotheses regarding the small GTPases in cell 
migration began to evolve. RhoA was found to be active at the 
leading edge of migrating cells. Importantly, the three major Rho 
small GTPases (Rac1, Cdc42 and RhoA) were all activated at the 
front of the migrating cells in a spatial and temporal manner, 
such that RhoA activation preceded that of Rac and Cdc42.20,21 
These studies added validity to previous studies,9,11,12,22 including 
our own,13,23 that implicated RhoA in membrane ruffling and 
lamellae formation and, therefore, an important role in the pro-
trusive events at the leading edge that drive cell motility.
How RhoA switches from stress fibers to lamellae formation is 
unclear. It is tempting to speculate that the choice of one effector 
controls this fate; however, both membrane ruffling and stress 
fiber formation are mediated through the Rho effectors ROCK 
and mammalian homolog of Drosophila diaphanous (mDia).24 
To understand how this switch occurs, we will first discuss what 
we know about RhoA effectors and stress fiber formation.
Rho Effectors and Stress Fiber Formation
The effectors of small Rho GTPases comprise of a variety of pro-
teins including lipid kinases, scaffold proteins, and serine/threo-
nine kinases that can be classified into discrete classes based on 
how they bind the switch regions of Rho.22,25 Although RhoA, 
RhoB and RhoC share overlapping effectors, whether the prefer-
ence of each isoform for different effectors contributes to distinct 
effect on cell behavior has not been fully elucidated. Among these 
effectors, however, ROCK and mDia have been most extensively 
studied and their role in stress fiber formation well documented.
ROCK is a major mediator of Rho function. Inhibition of 
ROCK blocks the formation of most Rho-mediated actin cyto-
skeletal structures, including stress fibers. ROCK inactivates 
myosin phosphatase by phosphorylation of its myosin-binding 
subunit as well as direct phosphorylation and activation of myo-
sin light chain. As a consequence, ROCK enhances actomyosin 
contractility.22 The resulting contraction on the actin filaments 
leads to the bundling of actin fibers and the clustering integ-
rins into focal adhesions.15,26 However, constitutive activation of 
ROCK is insufficient to promote stress fiber formation, suggest-
ing that ROCK is necessary but not sufficient. Notably, actin 
polymerization is also required. As shown in Figure 1, other 
effectors downstream of RhoA including phosphotidylinositide 
4P-5 kinase (PI4P-5K) and mDia have been shown to stimulate 
actin polymerization.24,27,28 Furthermore, ROCK-mediated phos-
phorylation and activation of LIM kinase (LIMK) facilitates 
actin polymerization by stabilizing actin filaments by inactivat-
ing the actin severing functions of cofilin29 (Fig. 1). These obser-
vations support the cooperation of ROCK and mDia in stress 
fiber formation.
During their formation, stress fibers lead to the generation of 
focal adhesions and, in the absence of adequate focal adhesion 
GTPases in cell migration, tumor cell invasion and metastasis 
are changing.
This mini-review focuses on recent studies that shed light on 
how conditional signaling can influence the functional output 
of RhoA signaling. Specifically, we will discuss the mechanisms 
of how RhoA signaling, in conjunction with the Rho effec-
tor Rhotekin and the pro-metastatic calcium binding protein 
S100A4, can promote membrane protrusions such as lamel-
lipodial ruffles in lieu of stress fibers. We will further discuss 
how these RhoA functions associate with cell migration and 
invasion in two-dimensional (2D) and three-dimensional (3D) 
environments.
RhoA in Cell Migration
The importance of Rho proteins in cell migration and invasion 
is now well established; however, it has not always been so. The 
role of RhoA in cell migration at one time was considered by 
many to be dispensable or inhibitory to cell migration. Several 
factors lead to the early conclusion. Primarily the observation 
that RhoA promotes stress fibers and strong adhesion through 
focal adhesion formation guided the path to this deduction 
(reviewed in refs. 4 and 15). There also exists a reciprocal rela-
tionship between RhoA and Rac1 in which high Rac activity 
leads to the reduction of Rho and vice versa.16,17 Since Rac is 
instrumental for lamellae formation and cellular protrusions 
it seemed logical that RhoA would be inhibitory to these pro-
cesses. Finally, the involvement of p190RhoGAP in cell spread-
ing and migration,18 as well as the induction of RhoC in the 
metastatic process3 cemented this concept that RhoA might be 
detrimental to, or at least dispensable for, cell migration and 
invasion.
Figure 1. RhoA mediated pathways to actin polymerization and acto-
myosin contractility. RhoA facilitates actin polymerization by positively 
regulating multiple effectors and kinases (arrows) as well as through 
the negative regulation of cofilin by the ROCK-LIMK pathway (blunted 
lines). Through parallel pathways, the RhoA-ROCK pathway also leads to 
myosin mediated actin contraction by inhibition of myosin phospha-
tase or through the direct phosphorylation of MLC.
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altering the ratio of ROCK to mDia can influence these processes. 
Additional mechanisms to regulate actin polymerization are pres-
ent downstream of RhoA (Fig. 2). Notably, adducin phosphory-
lation by ROCK has been shown to be an instrumental aspect of 
the pro-ruffling features of ROCK signaling.11 However, these 
effectors offer more of a sliding scale than a discrete switch.
Work from our lab has shown that integrin α6β4 promotes 
membrane ruffling and lamellae formation in carcinoma cells, 
which are mediated by RhoA.13,23,32 Notably, other reports impli-
cating RhoA in membrane ruffling came from cells of epithelial 
origin9,11,12 that also express integrin α6β4. The most dramatic 
example of this concept is seen in the MDA-MB-435 cells. In 
the absence of integrin α6β4 expression, these cells utilize RhoC 
for migration and do not form lamellae in response to LPA. 
However, integrin α6β4 signaling facilitates RhoA activation 
and RhoA-dependent membrane ruffles and lamellae with LPA 
stimulation, which in turn dramatically enhances cell migration 
and invasion.23,32 These observations suggest that integrin α6β4 
may hold the key to how the function of RhoA is switched from 
stress fibers to lamellae formation. Through our transcriptome 
studies on integrin α6β4 in breast, we found that integrin α6β4 
controls the expression of the pro-metastatic gene S100A4.33 In 
the next section, we discuss our recent finding that S100A4 binds 
the Rho effector Rhotekin to form a complex with RhoA, which 
in turns changes RhoA function to permit this GTPase to stimu-
late membrane ruffling in lieu of stress fibers.
Rhotekin and S100A4 Navigate the Switch
Rhotekin is a scaffold protein that was initially identified as a puta-
tive target for Rho that interacts with both RhoA and RhoC.34 
The search for Rhotekin interacting proteins focused on the 
C-terminal domain since it contains a consensus binding motif 
for Class I PDZ proteins. Rhotekin was found to interact with 
vinexin, Lin7B, PIST and septin, which are considered to play 
roles in cell polarity, focal adhesion and septin organization.35-37 
turnover, are associated with non-motile cells. Constitutive acti-
vation of RhoA has been demonstrated to negatively regulate 
cell migration due to excess stress fiber formation and adhesion 
forces.30,31 Inhibition of ROCK under conditions where RhoA 
activity is high or altering the ratio of ROCK to mDia can reduce 
stress fiber thickness and favor cell migration.15,22 These studies 
support the concept that the contractility downstream of RhoA 
activity must be tempered in order for membrane protrusions to 
dominate. Notably, most advanced carcinomas do not form true 
stress fibers, but rather thinner contractile filaments (which are 
often referred to as stress fibers for lack of a better term) that 
are conducive to cell migration. These observations suggest that 
advanced carcinoma cells acquire a mechanism to temper RhoA-
ROCK mediated contractility to permit the protrusive events 
downstream to predominate.
RhoA Function at the Leading Edge
The membrane protrusions at the leading edge, including filo-
podia and lamellae, are well known to be regulated by Cdc42 
and Rac, respectively. However, in cells with epithelial origin, 
RhoA is active in the leading edge, as shown by using fluores-
cence-based Rho biosensors,9,10,20 where it promotes membrane 
ruffling and facilitates cell motility.9,11-13 In 2000, we were the 
first to publish that RhoA could promote the formation of lamel-
lae in the absense of Rac1. We showed that the engagement of 
the integrin α6β4 with laminin in Clone A colon carcinoma 
cells produced RhoA-dependent membrane ruffles and lamellae 
that were instrumental for haptotaxis of these cells.13 While quite 
heretical at the time, the concept that RhoA activity can localize 
at the leading edge to drive migration was validated using RhoA 
biosensors which demonstrated that RhoA activity localized to 
the leading edge of fibroblasts. Shortly thereafter, Kurokawa et 
al. found that RhoA is not only active in the leading edge but 
also in the rear of HeLa cells during random migration on col-
lagen. They further demonstrated that RhoA activity persists in 
membrane ruffles upon growth factor stimulation in Cos1 and 
NIH3T3 cells and that RhoA activity was required for the induc-
tion of membrane ruffles.9
These concepts led to confusion regarding the timing of acti-
vation and the relationship among the small GTPases at the lead-
ing edge. To answer this question, collaborative efforts between 
the Hahn and Danuser labs assessed the activation of RhoA, 
Rac1 and Cdc42 in the same cells under growth factor stimula-
tion. They found that the activation of RhoA synchronized with 
protrusions, was restricted to within 2 μm of the leading edge, 
and preceded the activation of Rac and Cdc42.20 This restriction 
and slight separation of Rac and Rho activities from each other 
helps to explain how integrin- and Rac-activated GAP activities 
could co-exist with RhoA at the leading edge. Furthermore, it 
highlights that RhoA activity at the leading edge must be deli-
cately regulated by positive and negative regulators in order for 
RhoA to promote membrane protrusions.
How RhoA regulates two very different processes such as 
stress fibers and membrane ruffling is puzzling. A mechanism for 
switching these two functions must exist. As mentioned above, 
Figure 2. RhoA signaling toward actin polymerization and actomyosin 
contractility is delicately balanced. While RhoA signals to actin polym-
erization as well as myosin-mediated actin filament contraction, tipping 
this balance toward more actin polymerization facilitates membrane 
ruffling and lamellae formation, while higher contractile forces lead to 
stress fiber formation.
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change in RhoA functional output. Using MDA-MB-231 stim-
ulated with EGF as a model, we found that RNAi-mediated 
suppression of S100A4 and Rhotekin switched Rho from medi-
ating membrane ruffling and lamellae to thick contractile stress 
fibers.
In Figure 3, we depict our working model of this concept of 
how S100A4 and Rhotekin cooperate to alter RhoA function. 
Central to this concept is the fact that S100A4 binds to the myo-
sin IIA heavy chain to prevent its oligomerization and temper 
contractility. As shown in Figure 3A, we propose that when 
cells express both Rhotekin and S100A4, growth factor stimu-
lation of Rho activity leads to the coupling of Rho to S100A4. 
Under these conditions, myosin II oligomerization is restricted 
within close proximity to active Rho, thus limiting stress fiber 
formation. The inhibition of myosin-mediated actin contractil-
ity then permits membrane ruffling and lamellae formation to 
predominate downstream of Rho effectors such as ROCK. In 
the absence of S100A4 and Rhotekin, RhoA activation and non-
oligomeric myosin do not colocalize, therefore the contractility 
events downstream of RhoA signaling predominate leading to 
stress fiber formation (Fig. 3B).
Contractility that limits the rate of membrane ruffling and 
protrusions occurs beyond the lamellipodium into the lamella 
where myosin IIA mediates retrograde actin flow. Notably, the 
rate of cellular protrusions is inversely correlated with retrograde 
actin flow within lamellae such that blocking myosin IIA by 
siRNA or blebbistatin can increase membrane protrusions.55,56 If 
the modulation of actomyosin contractility by S100A4 extends 
beyond the lamellipodium (where RhoA is localized and sig-
nals) into the lamella (where MLCK has been shown to be more 
active57), it would suggest that that S100A4 could facilitate RhoA 
signaling and membrane protrusion by restricting retrograde 
flow within the lamella through the modulation of myosin IIA 
contractility regulated by other pathways. However, to determine 
if these mechanisms are in fact coupled and coordinated in such 
a manner will require further analysis.
RhoA in 3D Invasion
While RhoA has been shown to function in 2D migration sys-
tems, there are clearly conditions in which RhoA is dispens-
able for or inhibitory to cell migration. However, with the use 
of more physiological assessments of tumor cell invasion and 
3D invasive growth, RhoA becomes much more influential. 
The mechanisms governing invasion of carcinoma cells in 3D 
and in vivo differ greatly from those in 2D culture. First and 
foremost, the tension supplied in 2D cultures comes from the 
glass or plastic support on which cells are plated. In 3D cultures 
and in vivo, the tension in the matrix must be supplied by the 
tumor cells themselves or from nearby stromal cells. Alignment 
of the collagen fibers found in the stroma is diagnostic for 
tumor aggressiveness58 and has been shown by the Condeelis 
and Segall groups to facilitate tumor cell migration along these 
filaments in vivo.59 The concept that Rho contributes to ten-
sion within the tumor microenvironment has been validated by 
Provensano and Keely where they elegantly showed that Rho 
Rhotekin was also found to be overexpressed in metastatic colon 
cancer38 and gastric adenocarcinoma cells and confers resistance 
to apoptosis through activation of NF-κB.39 Further impact on 
transcription was shown through the interaction of Rhotekin 
and TIP-1 with active Rho which strongly activate SRE (serum 
response element).37 A recent study revealed that Rhotekin is a 
substrate of Protein kinase D (PKD). Although there is no physi-
cal interaction between Rhotekin and PKD, the authors found 
that PKD induced Rhotekin phosphorylation at serine 435. This 
phosphorylation event significantly increase membrane anchor-
ing of RhoA as well as RhoA activity, thereby promoting actin 
stress fiber formation in NIH-3T3 cells.40 Despite these find-
ings, the role of Rhotekin in Rho-mediated downstream sig-
nal transduction leading to actin cytoskeleton reorganization 
remained largely unknown. This may be because the domain 
of Rhotekin that influences the cytoskeleton is the Rho bind-
ing domain (RBD). Based on our recent serendipitous finding 
that S100A4 can bind the RBD of Rhotekin, we have uncovered 
a new function for Rhotekin that may help explain its role in 
tumor progression.
S100A4 is a calcium binding EF-hand protein that belongs to 
the S100 superfamily that contains at least 21 family members. 
It was cloned independently from various cell types under differ-
ent names including metastasin-1 (mts1), CAPL and fibroblast 
specific protein (FSP1), 18A2, pEL98, p9Ka, 42A and calvas-
culin.41,42 S100A4 is associated with the progression of a variety 
of cancers, including breast, prostate, pancreatic, gallbladder, 
colon, gastric, lung and melanoma41-44 and has been considered 
as a valuable prognostic marker for several tumors including 
breast and colon.45,46 The role of S100A4 in tumor progression, 
and specifically on tumor metastasis, was also documented in 
several types of cancer by experimental metastasis and geneti-
cally-modified mouse models.41,42 Although S100A4 was initially 
identified as a fibroblast marker,47 investigations on S100A4 
expression demonstrated that it is expressed in highly motile 
cell types, including T-lymphocytes, neutrophils, macrophages, 
platelets, endothelial cells, fibroblast and carcinoma cells.41,42,48 
Notably, cell motility has been implicated as a major function 
controlled by S100A4.43 Intracellularly, S100A4 interacts with 
target proteins such as heavy chain of non-muscle myosin IIA 
(MHC-IIA),49 tropomyosin50 and liprin β1.51 Most notably, the 
interaction of S100A4 with myosin IIA heavy chain inhibits 
myosin IIA phosphorylation, promotes myosin disassembly and 
reduces the contractility of myosin; this well-defined feature of 
S100A4 represents a major mechanism of how S100A4 mediates 
cell motility and invasion.41,52,53
In a recent study from our group,54 we found that S100A4 
specifically bound the RBD of Rhotekin, but not the RBDs of 
other class I effectors or critical Rho effectors such as ROCK or 
mDia. We further determined that S100A4 bound a region of 
the RBD distinct from where RhoA bound. This observation 
led to the discovery that active RhoA-Rhotekin and S100A4 
could form a complex. Despite the proposed role of Rhotekin in 
maintaining Rho in an active conformation, we saw no changes 
in RhoA activity with Rhotekin and/or S100A4 knockdown 
(unpublished observation). Instead, we discovered a functional 
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RhoA Cooperation with Other Small GTPases
There is still much to be deciphered regarding how RhoA pro-
motes membrane ruffling. Despite the abilities of RhoA to stimu-
late actin polymerization through multiple effectors, it rarely works 
alone in this process. In many cell types, either Rac or Cdc42 is 
activated in conjunction with RhoA.9,21,23 Both Rac and Cdc42 
signal through Pak1 to stimulate LIMK, which then phosphory-
lates and inactivates cofilin to prevent cleavage of actin fibers. This 
represents a convergence point with RhoA-ROCK pathway that 
facilitates F-actin polymerization. However, Rac and Cdc42 both 
signal through either WAVE or WASP proteins to stimulate the 
Arp2/3 complex, a process not recognized as a Rho function, which 
may be necessary for actin branching during lamellae formation. 
Alternatively, Rac and Cdc42 have been suggested to recruit mDia 
to Rho,9 thus facilitating lamellae formation.
The studies to date on Rho in membrane ruffling and lamel-
lae formation have implicated RhoA. However, is it possible 
signaling in this context to be a major contributor to tumor 
aggressiveness.60-62
Certainly the role of Rho proteins in 3D invasive growth 
is more complex than the tension placed on the extracellular 
matrices. In our study,54 we found that simultaneous reduction 
of Rhotekin and S100A4 led to the collapse of invasive struc-
tures thus limiting cells to the formation of acinar structures in 
3D breast carcinoma model. If our hypotheses are correct, cells 
without S100A4 and Rhotekin would exert greater tension on 
the matrix, yet still do not demonstrate invasive growth. Clearly 
the concept of balancing protrusive events and contractility 
remains relevant to the 3D environment. Perhaps in the absence 
of protrusion-promoting signals, the default is to form tighter 
cell:cell adhesion and an acinar structure. To fully understand 
the role of Rho proteins in 3D invasive growth and the invasive 
process in vivo, our concepts must evolve as we improve our 
understanding of how cells interact with their microenviron-
ment under more physiological conditions.
Figure 3. Mechanisms of S100A4-Rhotekin-RhoA crosstalk in mediating membrane ruffling. (A) We propose that S100A4-mediated inhibition of 
myosin IIA heavy chain oligomerization limits the contractility of pMLC-myosin IIA complex. Under this condition, the actin polymerization functions 
of ROCK (shown here) and other effectors such as mDia (not shown) predominate, thus permitting the formation of lamellae. The lower panel depicts 
MDA-MB-231 cells stimulated with EGF for 5 min and then stained with phalloidin. (B) In the absence of S100A4 and Rhotekin, Rho/ROCK-mediated 
MLC phosphorylation in the presence of oligomers of myosin IIA facilitates the contractility required for stress fiber formation, while preventing 
membrane ruffles downstream of RhoA from forming. The lower panel represents an extreme phenotype of MDA-MB-231 cells with RNAi-mediated 
reduction of S100A4 and Rhotekin that were stimulated with EGF for 5 min and then stained with phalloidin.
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Concluding Remarks
Tumor invasive growth is a complex, multistep program involved 
in the interplay of tumor cells and the microenvironment, and 
in turn tumor cells acquire the propensity for migration, inva-
sion and proliferation.64 Rho signaling is engaged in at least two 
distinct types of motility in three-dimensional matrix, amoeboid 
motility and mesenchymal motility.65 Interestingly, these two 
types of migration are interchangeable. Beyond this versatility, 
we highlight new pathways involving the Rho effector Rhotekin 
and the metastasis associated S100A4 that direct Rho signaling 
from migration-inhibiting stress fibers to migration- and invasion-
promoting lamellipodial ruffles and lamellae. These observations 
highlight the amazing dynamics of RhoA signaling, which dra-
matically impacts how we view RhoA signaling during cancer 
invasion and ultimately the metastatic process. Furthermore, these 
studies demonstrate how contractility functions of RhoA can be 
tempered to favor actin polymerization; and that the protrusive 
functions of RhoA are as critical for tumor progression as its 
impact on cellular traction, matrix tension, and actin contractility.
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that RhoA and RhoC could share functions in these processes 
or potentially swap roles under select conditions? RhoA and 
RhoC share high homology and activate many of the same 
effectors, including ROCK, mDia and Rhotekin.22,34 While 
the absolute affinities of each of these shared effectors for the 
individual GTPases has not been systematically assessed, it is 
likely that subtle differences in affinities could affect effector 
choice. Alternatively, GTPase localization through its hyper-
variable region or select activation by specific GEFs could ulti-
mately govern the individual function of the two GTPases. 
Considering the evidence for RhoA at the leading edge, it is 
possible that RhoA functions in membrane ruffling and lamel-
lae formation while RhoC functions in the cell body to medi-
ate actin cytoskeletal contraction and trailing edge retraction. 
However, in a recent study by Anne Ridley’s group, RhoC 
was found to specifically bind FMNL3, which may help to 
define differences between RhoA and RhoC functions dur-
ing carcinoma cell migration. In that study, they suggest that 
RhoA functions at the leading edge to mediate membrane ruf-
fling while RhoC contracts the base of the lamellae to prevent 
lamellae broadening and loss of orientation.63 This study is an 
important example of the cooperation of RhoA and RhoC in 
cell migration. How RhoA and RhoC parcel out their duties 
during tumor invasion and how these functions change in a 3D 
environment will require further investigation.
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